BriaCell Therapeutics (BCTX) Income from Non-Controlling Interests (2023 - 2026)
BriaCell Therapeutics' Income from Non-Controlling Interests was -$72,548 in fiscal Q3 2026 (quarter ended Apr 30, 2026), compared with -$98,027 a year earlier.
Powered by 
Analysis
BriaCell Therapeutics (BCTX) Income from Non-Controlling Interests (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, BriaCell Therapeutics' Income from Non-Controlling Interests was -$301,121 through Apr 30, 2026; for FY2025 (ended Jul 31, 2025), it was -$244,273.
- In earlier fiscal years, Income from Non-Controlling Interests was -$140,082 in FY2024.
- The fiscal Q3 2026 figure marks the highest quarterly Income from Non-Controlling Interests since fiscal Q2 2025.
- Per Business Quant data, BCTX's Income from Non-Controlling Interests in the three fiscal quarters before Q3 2026 was -$75,073 (Q2 2026), -$80,763 (Q1 2026) and -$72,737 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | BriaCell Therapeutics | 29.29 Mn | 28.64 Mn | - | -72,548.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -72,548.00 |
| Jan 31, 2026 | -75,073.00 |
| Oct 31, 2025 | -80,763.00 |
| Jul 31, 2025 | -72,737.00 |
| Apr 30, 2025 | -98,027.00 |
| Jan 31, 2025 | -46,408.00 |
| Oct 31, 2024 | -27,101.00 |
| Jul 31, 2024 | -34,587.00 |
| Apr 30, 2024 | -23,517.00 |
| Jan 31, 2024 | -39,307.00 |
| Oct 31, 2023 | -42,671.00 |
API Access
BriaCell Therapeutics Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=BCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "BCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=BCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();